Results 201 to 210 of about 8,194 (217)

Systemic Amyloidosis: Is It ATTR or AL?

The American Journal of Medicine, 2023
Joel Singh, Jennifer Oliver-Krasinski, James Tauras, Benjamin T. Galen   +3 more
openaire   +2 more sources

ATTR Amyloidosis

2016
openaire   +1 more source

Transthyretin Amyloidosis (ATTR-CM)

Cardiovascular Research Prove Journal
openaire   +2 more sources

CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis

JACC: Cardiovascular Imaging, 2014
Dorota Rowczenio, Helen J Lachmann, Ashutosh D Wechalekar   +2 more
exaly  

Imaging Of ATTR Cardiac Amyloidosis

Radiopaedia 24 rPosters
Isaac Law, Shankar Vamadevan
openaire   +1 more source

Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2018
Vaishali Sanchorawala, Lawreen H Connors, Frederick L Ruberg   +2 more
exaly  

Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2015
Hiroshi Morita
exaly  

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

New England Journal of Medicine
Marianna Fontana, Scott Solomon, David Lebwohl   +2 more
exaly  

Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis

Cardiovascular Pathology, 2016
James R Stone
exaly  

Vutrisiran for ATTR Amyloidosis with Cardiomyopathy

New England Journal of Medicine
openaire   +2 more sources